Christopher Robert Bowie, PhD Updated 12 March 2014

Transcription

1 CR Bowie, p. 1 CURRICULUM VITAE Christopher Robert Bowie, PhD Updated 12 March 2014 Work Address: Queen s University Department of Psychology Kingston, Ontario K7L 3N6 Canada Tel Fax christopher.bowie@queensu.ca Website: CURRENT POSITIONS Primary Appointment: Associate Professor, Department of Psychology, Queen s University (July 1, 2012) Other Appointments: Head Consulting Psychologist, Head s Up! Early Intervention for Psychosis Program, Kingston, ON Clinician-Scientist (Part-Time) Centre for Addiction and Mental Health, Toronto, ON Cross-Appointments Associate Professor, Department of Psychiatry, Queen s University (cross-appointed July 1, 2008) Member, Centre for Neuroscience Studies, Queen s University Member, Queen s Biological Communication Centre, Queen s University EMPLOYMENT HISTORY Assistant Professor Department of Psychology, Queen s University Assistant Professor Mount Sinai School of Medicine Clinical Psychologist Bronx Veteran s Affairs Medical Center Applied Behavior Science Specialist Epilepsy Foundation of Long Island Instructor Mount Sinai School of Medicine Assistant Psychologist/Post-Doctorate in Neuropsychology The Recognition and Prevention Program (B. Cornblatt, PhD, Mentor) The Zucker Hillside Hospital of the North-Shore LIJ Health System Neuropsychological Examiner The Epilepsy Foundation of Long Island Neuropsychology Research Fellowship Mount Sinai School of Medicine (P.Harvey, PhD, Mentor) Assistant Research Coordinator

2 The Zucker Hillside Hospital of the North-Shore LIJ Health System Clinical Psychology Intern Pilgrim Psychiatric Center CR Bowie, p. 2 RESEARCH INTERESTS Neurocognition in Psychosis Functional Outcomes in Psychotic Disorders Novel Behavioral Assessment Methods Early Intervention and Prevention of Severe Mental Illness Pharmacological and Behavioral Treatment of Cognitive Deficits LICENSE New York State Licensed Psychologist # College of Psychologists of Ontario, Certificate in Clinical Psychology (Certificate Number 4913) EDUCATION Hofstra University, Clinical/School Psychology M.A. Awarded, August 1997 Ph.D. Awarded, June 2002 Dissertation Title: "Neurocognition, Symptomatology, and Social-Adaptive Functioning in Alcohol-Abusing Schizophrenia Patients" State University of New York, Oswego, Psychology B.A. with Honors Awarded, May 1996 HONORS AND AWARDS American Psychological Society (Now Association for Psychological Science) Graduate Student Grant Program: First Prize for Ph.D. Dissertation, June 2002 The New York State Office of Mental Health Achievement Award in the Area of Services Research for 2002 National Alliance for Research in Schizophrenia and Depression Young Investigator's Award, 2003 Schizophrenia Global Medical Conference Young Investigator Travel Award, 2004 National Institute of Health Student Loan Repayment Award, 2004 National Alliance for Research in Schizophrenia and Depression Young Investigator's Award, 2007 Winter Conference on Brain Research Travel Fellowship, 2011 *Ann Kelley Memorial Fellowship as top rated fellow Queen s University Office of Research Services Travel Award, 2011

3 CR Bowie, p. 3 Ontario Ministry of Research and Innovation Early Researcher Award, 2011 Brain and Behavior Research Foundation Independent Investigator Award, 2013 TEACHING Mount Sinai School of Medicine Classification of Memory Disorders Differential Diagnosis of Geriatric Depression ( Pseudodementia ) and Dementia Differential Diagnosis of Psychotic Disorders Neuroscience Seminar Series Neuropsychiatry of Schizophrenia Neuropsychology of Schizophrenia Research Methodology Statistics Queen s University Undergrad Abnormal Psychology Psychotic Disorders Seminar Graduate Adult Psychopathology Behaviour Therapy for Serious Mental Illnesses ADMINISTRATIVE Bronx Veterans Affairs Medical Center Institutional Review Board Member Supervisor of MIRECC Psychology Fellows Mount Sinai School of Medicine Director of clinical assessment: Conte Neuroscience Center Queen s University Manager of Clinical Program Website 2010-active Clinical Program Comprehensive Examination Committee Merit Committee Colloquium Coordinator Undergraduate Committee ADVISING/SUPERVISION Thesis Committee Supervisor Maya Gupta, Clinical Psychology, Queen s University, 2011, M.Sc. Thesis: Understanding treatment-resistant depression: the complicated relationships among neurocognition, symptoms, and functioning. Katherine Holshausen, Clinical Psychology, Queen s University, 2012, M.Sc. Thesis: Structured Therapy for the Enhancement of Purposeful Speech (STEPS): A Step in the right direction to treating formal thought disorder in Schizophrenia.

4 Michael W. Best, Clinical Psychology, Queen s University, 2013, M.Sc. Thesis: Neurophysiological Behavioural Responses to Schizophrenia-Associated Communication Abnormalities CR Bowie, p. 4 Chair Christine Lackner, Queen s University, 2009, M.Sc. Thesis Graham Raynor, Queen s University, 2011, M.Sc. Thesis External Examiner Margarita Bougioukas, Clinical Psychology, Hofstra University, 2008, Ph.D. Thesis Committee Member Allisha Patterson, Clinical Psychology, Queen s University, 2009, M.Sc. Thesis Sylvia Magrys, Clinical Psychology, Queen s University, 2009, M.Sc. Thesis Ashley Vanstone, Clinical Psychology, Queen s University, Ph.D. Thesis (in progress) Julie Burbidge, Clinical Psychology, Queen s University, 2013, Ph.D. Thesis Cherie La Roque, Clinical Psychology, Queen s University, 2010 M.Sc. Thesis Laura Katz, Clinical Psychology, Queen s University, 2010 M.Sc. Thesis Nida Latif, Brain, Behaviour, and Cognitive Sciences, Queen s University, 2012 M.Sc. Thesis Ryland Steel, Neuroscience, Queen s University, M.Sc. Thesis (2013) Adam Heenan, Clinical Psychology, Queen s University, Ph.D. Thesis (in progress) Cherie La Roque, Clinical Psychology, Queen s University, Ph.D. Thesis (in progress) Celina Nahanni, Neuroscience, Queen s University, Ph.D. Thesis (in progress) Post-Doctoral Fellows Winnie Leung, Ph.D., Mount Sinai School of Medicine, Undergraduate Honour s Psychology Students 2009 Shannon Xavier, Queen s University: Neurocognition, functional capacity and real-world outcomes in psychometrically defined schizotypy Emma Bassett, Queen s University: Neurocognitive and functional deficits in undergraduate students with elevated depressed 2010 Michael Levi, Queen s University: An evoked potential examination of emotional processing in schizophrenia Theresa Bernard, Queen s University: The association between hypomania, self-reported confidence, and betting: an investigation into goal dysregulation 2011 Lisa Gou, Queen s University: Does Misery Love Company? Non-conscious Social Mimicry as a Function of Depressive Symptoms and Conversational Partner Affect Lauren David, Queen s University: Deconstructing the Wisconsin Card Sorting Test: Investigating cognitive impairments in schizophrenia using psychophysical and behavioural assessment Laura Stefanik, Queen s University: Explaining neurocognitive variance in functioning in schizophrenia using eye movement and performance-based measures 2012 Sarah Oullettte, Queen s University: Measuring Stigmatizing Attitudes toward Schizophrenia: A Comparison of Traditional and Novel Approaches Erin Meiklejohn, Queen s University: Influence of Psychiatric Labels and Schizophrenia Symptom Behaviours on Nonverbal Behaviours during Interpersonal Interactions 2014

5 CR Bowie, p. 5 Caitlin Heino, Queens University: Demonstrating continuity in hallucinations and delusions: A novel method of stigma reduction Jennifer Rigby, Queen s University: Reducing stigma towards schizophrenia with education: A cognitive behavioural theory-approach to group intervention. Supervised Graduate Students Maya Gupta, M.Sc. currently a Ph.D. student in Clinical Psychology at Queen s University Michael Grossman, currently a Ph.D. student in Clinical Psychology at Queen s University Katherine Holshausen, currently a Ph.D. student in Clinical Psychology at Queen s University Mike Best, currently a Ph.D. student in Clinical Psychology at Queen s University Awards for Supervised Students Canadian Psychological Association Award for Undergraduate Thesis, 2009 (Shannon Xavier) Canadian Institute of Health Research Student Fellowship, 2010 (Katherine Holshausen) Canadian Institute of Health Research Student Fellowship, 2010 (Maya Gupta) Ontario Graduate Scholarship Fellowship, 2011 (Maya Gupta) Cognitive Remediation in Psychiatry, 2011: Best Student Poster Presentation (Maya Gupta) Canadian Psychological Association Clinical Section Travel Award, 2011 (Katherine Holshausen) Canadian Psychological Association Clinical Section Travel Award, 2011 (Maya Gupta) Ontario Graduate Scholarship Fellowship, 2012 (Katherine Holshausen) Cognitive Remediation in Psychiatry, 2011: Best Student Poster Presentation (Michael Grossman) Canadian Institute of Health Research Doctoral Student Fellowship, 2013 (Maya Gupta) Vanier Award, 2013 (Katherine Holshausen) Canadian Institute of Health Research Doctoral Student Fellowship, 2014 (Katherine Holshausen) Vanier Award, 2014 (Michael Best) Canadian Institute of Health Research Doctoral Student Fellowship, 2014 (Michael Best) Social Sciences and Humanities Research Council Doctoral Student Award, 2014 (Michael Grossman) PROFESSIONAL AFFILIATIONS Association for Psychological Science Canadian Psychological Association Schizophrenia International Research Society Society for Research in Psychopathology Society for a Science of Clinical Psychology PROFESSIONAL ACTIVITIES Program Committee, Society for Research in Psychopathology, 2009 Fellowship Committee, Ontario Mental Health Foundation, Chair, International Advisory Board, New Zealand and Australian Journal of Psychiatry Present Consulting Editor, Journal of Abnormal Psychology 2012-Present Editorial Board, Schizophrenia Research: Cognition, 2014-Present Committee Member, Canadian Institute for Health Research, Behavioural Sciences, 2014 AD HOC JOURNAL AND PUBLISHER REVIEWS

6 CR Bowie, p. 6 Acta Neuropsychiatrica, American Journal of Geriatric Psychiatry, American Journal of Psychiatry, American Psychological Association Press, Archives of General Psychiatry, Biological Psychiatry, Bipolar Disorders, CNS Spectrums, Community Mental Health Journal, European Psychiatry, Journal of Abnormal Psychology, Journal of the American Association of Psychiatric Nurses, Journal of Behavior Therapy and Experimental Psychiatry, Journal of Clinical and Experimental Neuropsychology, Journal of Clinical Psychopharmacology, Journal of Neurological Sciences, Journal of Nervous and Mental Disease, Journal of Psychiatric Research, Journal of Visualized Experiments, Neuropsychological Rehabilitation, Neuropsychopharmacology, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Psychiatric Services, Psychological Medicine, Psychosomatics, Schizophrenia Bulletin, Schizophrenia Research, Social Psychiatry and Psychiatric Epidemiology EXTERNAL GRANT REVIEWER North Shore LIJ Research Institute 2006 Ontario Mental Health Foundation 2006 The Netherlands Organisation for Health Research and Development 2008 Austrian Science Foundation 2011 Ireland Health Research Board 2012 National Institute for Health Research, U.K., 2013 ORIGINAL PEER-REVIEWED PUBLICATIONS (Number of Citations as of 25 June 2014 retrieved from Google Scholar) Supervised students and post-doctoral fellows are italicized 1. Bowie CR, Moriarty PJ, Harvey PD, Parrella M, White L, Davis KL. Aggression in elderly schizophrenia patients: A comparison of nursing home and state hospital residents. Journal of Neuropsychiatry and Clinical Neurosciences, 2001, 13, (23) 2. Friedman JI, Harvey PD, Coleman T, Moriarty PJ, Bowie C, Parrella M, White L, Adler D, Davis KL. Six-year follow-up study of cognitive functional status across the lifespan in schizophrenia: A comparison with Alzheimer s disease and normal aging. American Journal of Psychiatry, 2001, 158, (171) 3. Harvey PD, Serper MR, White L, Parrella MJ, McGurk, SR, Moriarty PJ, Bowie C, Vadhan N, Friedman J, Davis KL. The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia. Comprehensive Psychiatry, 2001, 42, (62)

7 CR Bowie, p Bowie CR, Harvey PD, Moriarty PJ, Parrella M, White L, Mohs RC, Davis KL. Cognitive assessment of geriatric schizophrenic patients with severe impairment. Archives of Clinical Neuropsychology, 2002, 17, (24) 5. Harvey PD, Moriarty PJ, Bowie C, Friedman JI, Parrella M, White L, Davis KL. Cortical and subcortical cognitive deficits in schizophrenia: Convergence of classifications based on language and memory skill areas. Journal of Clinical and Experimental Neuropsychology, 2002, 24, (18) 6. Harvey PD & Bowie CR. Cognitive deficits in schizophrenia: Early course and treatment. Clinical Neuroscience Research, 2003, 3, (11) 7. Auther AM, Lencz T, Smith CW, Bowie CR & Cornblatt BA. Overview of the first annual workshop on the schizophrenia prodrome. Schizophrenia Bulletin, 2003, 29, (10) 8. Harvey, P.D. & Bowie, C.R. Cognition in Schizophrenia: a review of recent findings. Current Psychosis and Therapeutics Reports, 2003, 1, Bowie CR, Harvey PD, Moriarty PJ, Parrella M, White L, Davis KL. A comprehensive analysis of verbal fluency deficit in geriatric schizophrenia. Archives of Clinical Neuropsychology, 2004, 19, (19) 10. Bowie CR, Reichenberg A, Rieckmann N, Parrella M, White L, Harvey PD. Stability and functional correlates of memory-based classification in older schizophrenia patients. American Journal of Geriatric Psychiatry, 2004, 12, (14) 11. Bowie CR, Serper MR, Riggio S Harvey PD. Neurocognition, symptomatology, and functional skills in older alcohol-abusing schizophrenia patients. Schizophrenia Bulletin, 2005, 31, (44) 12. Bowie CR & Harvey PD. Cognition in Schizophrenia: Impairments, Determinants, and Functional Importance. Psychiatric Clinics of North America, 2005, 28, (177) 13. Bowie CR. Cognitive impairment in schizophrenia spectrum personality disorders. Current Psychosis and Therapeutics Reports, 2005, 3, (2) 14. Harvey, PD & Bowie, CR. Ziprasidone: efficacy, tolerability, and emerging data on wide-ranging effectiveness. Expert Opinion in Pharmacotherapy, 2005, 6, (73) 15. Bowie CR, Tsapelas I, Friedman J, Parrella M, White L, Harvey PD. The longitudinal course of thought disorder in chronic geriatric schizophrenia patients. American Journal of Psychiatry, 2005, 162, (23) 16. Harvey PD, Bowie CR, Loebel A. Is cognitive improvement associated with switching to a new atypical antipsychotic sustained over time? A six-month extension study of patients switched to ziprasidone. Clinical Neuropsychiatry Journal of Treatment Evaluation, 2005, 2,

8 CR Bowie, p Rieckmann N, Reichenberg A, Bowie CR, Parrella M, White L, Harvey PD. Depressed Mood and Its Functional Correlates in Institutionalized Schizophrenia Patients. Schizophrenia Research, 2005, 77, (25) 18. Bowie CR, Reichenberg A, Patterson TL, Heaton RK, Harvey PD. Determinants of Real World Functional Performance in Schizophrenia Subjects: Correlations with Cognition, Functional Capacity, and Symptoms. American Journal of Psychiatry, 2006, 163, (344) 19. Harvey PD, Koren D, Reichenberg A, Bowie CR. Negative Symptoms and Cognitive Deficits: What is the nature of their relationship? Schizophrenia Bulletin, 2006, 32, (178) 20. Harvey PD, Bowie CR, Loebel A. Neuropsychological Normalization with Long-Term Atypical Antipsychotic Treatment: Results of a Six-Month, Randomized, Double-Blind Comparison of Ziprasidone vs. Olanzapine. Journal of Neuropsychiatry and Clinical Neurosciences, 2006, 18, (40) 21. Harvey PD, Friedman JI, Bowie C, Reichenberg A, Parrella M, White L, Davis KL. Validity and stability of performance-based estimates of premorbid educational functioning in older patients with schizophrenia. Journal of Clinical and Experimental Neuropsychology, 2006, 28, (19) 22. Bowie CR, Fallon C, Harvey PD. Convergence of Clinical Staff Ratings and Research Ratings to Assess Patients with Schizophrenia in Nursing Homes. Psychiatric Services, 2006, 57, (4) 23. Harvey PD, Green M, Loebel A, Bowie, C. The dimensions of clinical and cognitive change in schizophrenia: evidence for the independence of improvements. Psychopharmacology, 2006, 187, (47) 24. Chemerinski E, Reichenberg A, Kirkpatrick B, Bowie CR, Harvey PD. Three dimensions of clinical symptoms in elderly patients with schizophrenia: prediction of six-year cognitive and functional status. Schizophrenia Research, 2006, 85, (30) 25. Bowie CR & Harvey PD. Treatment of Cognitive Deficits in Schizophrenia. Current Opinion in Investigational Drugs, 2006, 7, (30) 26. Bowie CR & Harvey PD. Cognitive deficits and functional outcome in schizophrenia. Neuropsychiatric Disease and Treatment, 2006, 2, (47) 27. Bowie CR & Harvey PD. Schizophrenia from a neuropsychiatric perspective. Mount Sinai Journal of Medicine, 2006, 73, (14) 28. White L, Friedman JI, Bowie CR, Evers M, Harvey PD, Parrella M, Mihaila E, Davis KL. Longterm Outcomes In Chronically Hospitalized Geriatric Patients With Schizophrenia: Retrospective Comparison of First Generation and Second Generation Antipsychotics. Schizophrenia Research, 2006, 88, (25) 29. Bowie CR & Harvey PD. Administration and interpretation of the trail making test. Nature Protocols, 2006, 1, (135)

9 CR Bowie, p Harvey PD, Reichenberg A, Bowie C. Cognition and aging in psychopathology: focus on schizophrenia and depression. Annual Review of Clinical Psychology, 2006, 2, (22) 31. McClure MM, Zegarelli G, Bowie CR, Mitropoulou V, Siever LJ, Harvey PD. Cognitive impairment in the schizophrenia spectrum: What is the evidence for similarity to schizophrenia? Current Psychosis and Therapeutics Reports, 2006, 4, McClure MM, Bowie CR, Patterson TL, Heaton RK, Weaver C, Anderson H, Harvey PD. Correlations of functional capacity and neuropsychological performance in older patients with schizophrenia: evidence for specificity of relationships? Schizophrenia Research, 2007, 89, (77) 33. McClure MM, Bowie CR, Siever L, Harvey PD. Visual-Spatial Learning and Memory in Schizotypal Personality Disorder: Continued Evidence for the Importance of Working Memory in the Schizophrenia Spectrum. Archives of Clinical Neuropsychology, 2007, 22, (24) 34. Bowie CR & Jaga K. Methods for treating cognitive deficits in schizophrenia. Expert Review of Neurotherapeutics, 2007, 7, (11) 35. Buckley PF, Harvey PD, Bowie CR, Loebel A. The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone. Schizophrenia Research, 2007, 94, (37) 36. Bowie CR, Twamley EW, Anderson H, Halpern B, Patterson T & Harvey PD. Self-assessment of functional status in schizophrenia. Journal of Psychiatric Research, 2007, 41, (110) 37. Mausbach BT, Bowie CR, Harvey PD, Twamley EW, Goldman SR, Jeste DV, Patterson TL. Usefulness of the UCSD Performance-based Skills Assessment (UPSA) for predicting residential independence in patients with chronic schizophrenia. Journal of Psychiatric Research. 2008, 42, (59) 38. Bowie CR, Leung WL, Reichenberg A, McClure MM, Patterson TL, Heaton RK, Harvey PD. Predicting Schizophrenia Patients Real-World Behavior with Specific Neuropsychological and Functional Capacity Measures. Biological Psychiatry, 2008, 63, (252) 39. Leung WL, Bowie CR, Harvey PD. Functional implications of neuropsychological normality and symptom remission in older outpatients diagnosed with schizophrenia: a cross-sectional study. Journal of the International Neuropsychological Society, 2008, 14, (57) 40. Chemerinski E, Bowie CR, Anderson H, Harvey PD. Depression in schizophrenia: Methodological artifact or distinct feature of the illness? Journal of Neuropsychiatry and Clinical Neurosciences, 2008, 20, (27) 41. Kirkpatrick B, Messias E, Harvey PD, Fernandez-Egea E, Bowie CR. Is schizophrenia a syndrome of accelerated aging? Schizophrenia Bulletin, 2008, 34, (79)

10 CR Bowie, p Bowie CR, Harvey PD. Communication Abnormalities Predict Functional Outcomes in Chronic Schizophrenia: Differential Associations with Social and Adaptive Functions. Schizophrenia Research, 2008, 103, (32) 43. Bowie CR, Reichenberg A, McClure MM, Leung WL, Harvey PD. Age-associated differences in cognitive performance in older community dwelling schizophrenia patients: differential sensitivity of clinical neuropsychological and experimental information processing tests. Schizophrenia Research, 2008, 106, (18) 44. Yehuda R, Harvey PD, Golier J, Newmark RE, Bowie CR, Wohltmann JJ, Grossman RA, Schmeidler J, Hazlett EA, Buchsbaum M. Changes in Relative Glucose Metabolic Rate Following Cortisol Administration in Aging Veterans with Posttraumatic Stress Disorder: An FDG-PET Neuroimaging Study. Journal of Neuropsychiatry and Clinical Neurosciences, 2009, 21, (15) 45. Harvey PD, Keefe RSE, Patterson TL, Heaton RK, Bowie CR. Abbreviated Neuropsychological Assessment in Schizophrenia: Prediction of Different Aspects of Outcome. Journal of the International Neuropsychological Society, 2009, 31, (29) 46. Reichenberg A, Harvey PD, Bowie CR, Mojtabai R, Rabinowitz J, Heaton RK, Bromet E. Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophrenia Bulletin, 2009, 35, (145) 47. Leifker FR, Bowie CR, Harvey PD. Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms. Schizophrenia Research, 2009,115, (84) 48. Mausbach BT, Moore R, Bowie C, Cardenas V, Patterson TL. A review of instruments for measuring functional recovery in those diagnosed with psychosis. Schizophrenia Bulletin, 2009, 35, (58) 49. Harvey PD, Helldin L, Bowie C, Olsson AK, Hjarthag F, Torsten N, Heaton RK, Patterson TL. Performance-Based Measurement of Functional Disability in Schizophrenia: A Cross-National Study in the United States and Sweden. American Journal of Psychiatry, 2009;166, (68) 50. Harvey PD, Reichenberg A, Bowie CR, Patterson TL, Heaton RK. The course of neuropsychological performance and functional capacity in older patients with schizophrenia: influences of previous history of long-term institutional stay. Biological Psychiatry, 2010, 67, (30) 51. Mausbach BT, Harvey PD, Pulver AE, Depp CA, Wolyniec PS, Thornquist JR, McGrath JA, Bowie CR, Patterson TL. Relationship of the Brief UCSD Performance-based Skills Assessment (UPSA-B) to multiple indicators of functioning in people with schizophrenia and bipolar disorder. Bipolar Disorders, 2010, 12, (26) 52. Bowie CR, Depp C, McGrath JA, Wolyniec P, Mausbach BT, Thornquist MH, Luke J, Patterson TL, Harvey PD, Pulver AE. Prediction of Real World Functional Disability in Chronic Mental Disorders: A Comparison of Schizophrenia and Bipolar Disorder. American Journal of Psychiatry, 2010, 167, (127)

11 CR Bowie, p Leifker FR, Patterson TL, Bowie CR, Mausbach BT, Harvey PD. Psychometric Properties of Performance-based Measurements of Functional Capacity: Test-Retest Reliability, Practice Effects, and Potential Sensitivity to Change. Schizophrenia Research, 2010, 119, (32) 54. Depp CA, Mausbach BT, Harvey PD, Bowie CR, Wolyniec PS, Thornquist MH, Luke JR, McGrath JA, Pulver AE, Patterson TL. Social Competence and observer-rated social functioning in bipolar disorder. Bipolar Disorders, 2010, 12, (12) 55. Adelsky MB, Bowie CR, Goldberg TE, Serper MR. Adaptive competence impairment and cognitive deficits in acutely ill schizophrenia patients residing in nursing homes. American Journal of Geriatric Psychiatry, 2011, 19, (6) 56. Larochette AC, Harrison AG, Rosenblum Y, Bowie CR. Additive neurocognitive deficits in adults with ADHD and depressive symptoms. Archives of Clinical Neuropsychology, 2011, 26, (3) 57. Bowie CR, Gupta M, Holshausen K. Disconnected and underproductive speech in schizophrenia: Unique relationships across multiple indicators of social functioning. Schizophrenia Research, 2011, 131, (7) 58. Mausbach BT, Depp CA, Bowie CR, Harvey PD, McGrath JA, Thornquist MH, Luke JR, Wolyniec PS, Pulver AE, Patterson TL. Sensitivity and specificity of the UCSD Performance- Based Skills Assessment (UPSA-B) for identifying functional milestones in schizophrenia. Schizophrenia Research, 2011, 132, (13) 59. Harvey PD, McClure MM, Patterson TL, McGrath JA, Pulver A, Bowie CR, Siever LJ. Impairment in functional capacity as an endophenotype candidate in severe mental illness. Schizophrenia Bulletin, 2012, 38(6), (14) 60. Gupta M, Bassett E, Iftene F, Bowie CR*. Functional outcomes in schizophrenia: understanding the competence-performance discrepancy. Journal of Psychiatric Research, 2012, 46, *Corresponding author (15) 61. Loewenstein DA, Czaja SJ, Bowie CR, Harvey PD. Age-associated differences in cognitive performance in older patients with schizophrenia: a comparison with healthy older adults. American Journal of Geriatric Psychiatry, 2012, 20, (14) 62. Bowie CR, Mclaughlin D, Carrión RE, Auther AM, Cornblatt BA. Cognitive changes following antidepressant or antipsychotic treatment in adolescents at clinical risk for psychosis. Schizophrenia Research, 2012, 137, (6) 63. Harvey PD, Bowie CR. Cognitive Remediation in Severe Mental Illness. Innovations in Clinical Neuroscience, 2012, 9, 1-4. (1) 64. Mausbach BT, Roepke SK, Chattillion EA, Harmell AL, Moore R, Romero-Moreno R, Bowie CR, Grant I. Multiple mediators of the relations between caregiving stress and depressive symptoms. Aging and Mental Health, 2012, 16, (16)

12 CR Bowie, p Depp CA, Mausbach BT, Harmell AL, Salva GN, Bowie CR, Harvey PD, Patterson TL. Metaanalysis of the association between cognitive abilities and everyday functioning in bipolar disorder. Bipolar Disorders, 2012, 14, (21) 66. Depp CA, Mausbach BT, Bowie C, Wolyniec P, Thornquist MH, Luke JR, McGrath JA, Pulver AE, Harvey PD, Patterson TL. Determinants of occupational and residential functioning in bipolar disorder. Journal of Affective Disorders, 2012, 136, (5) 67. Gould F, Bowie CR, Harvey PD. The influence of demographic factors on functional capacity and everyday functional outcomes in schizophrenia. Journal of Clinical and Experimental Neuropsychology, 2012, 34, (8) 68. Gupta M, Holshausen K, Mausbach B, Patterson T, Bowie CR*. Predictors of change in functional competence and real world behavior following Functional Adaptation Skills Training for schizophrenia. Journal of Mental and Nervous Disease, 2012, 200, *Corresponding author (3) 69. Bowie CR, McGurk SM, Mausbach BT, Patterson TL, Harvey PD. Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real world behavior. American Journal of Psychiatry, 2012, 169, (48) 70. Harvey PD, Bowie CR. Cognitive enhancement in schizophrenia: Pharmacological and cognitive remediation approaches. Psychiatric Clinics of North America, 2012, 35(3), (4) 71. Chengappa KNR, Turkin SR, DeSanti S, Bowie CR, Brar JS, Schlicht PJ, Murphy SL, Hetrick ML, Bilder R, Fleet D. A preliminary, randomized, double-blind, placebo-controlled trial of L- Carnosine to improve cognition in schizophrenia. Schizophrenia Research, 2012, 142, (7) 72. Best M & Bowie CR*. Neurophysiological responses to schizophrenia-associated communication abnormalities. Schizophrenia Research, 2013, 148, *Corresponding Author 73. Cardenas V, Abel S, Bowie CR, Tiznado D, Depp CA, Patterson TL, Jeste DL, Mausbach BT. When functional capacity and real world functioning converge: the role of self-efficacy. Schizophrenia Bulletin, 2013, 39, (9) 74. Mausbach BT, Moore RC, Davine T, Cardenas V, Bowie CR, Ho J, Jeste DV, Patterson TL. The use of the theory of planned behavior to predict engagement in functional behaviors in schizophrenia. Psychiatry Research, 2013, 205, (2) 75. Bowie CR, Gupta M, Holshausen K. Cognitive remediation therapy for mood disorders: rationale, early evidence, and future directions. Canadian Journal of Psychiatry, 2013, 58, (5) 76. Bowie CR, Gupta M, Holshausen K, Jokic R, Best, M, Milev, R. Cognitive remediation for treatment resistant depression: Effects on cognition and functioning and the role of online homework. Journal of Nervous and Mental Disorders, 2013, 201, (2)

13 CR Bowie, p McClure MM, Harvey PD, Bowie CR, Iacoviello B, Siever LJ. Functional outcomes, functional capacity, and cognitive impairment in schizotypal personality disorder. Schizophrenia Research, 2013, 144, (2) 78. Gupta M, Holshausen K, Best M, Jokic R, Milev R, Bernard T, Gou L, Bowie CR*. Relationships among neurocognition, symptoms, functioning in treatment-resistant depression. Archives of Clinical Neuropsychology, 2013, 28, *Corresponding Author (2) 79. Best MW, Fitzpatrick M, Milev R, Bowie CR, Jokic R. Utility of the Berlin Questionnaire for Predicting Obstructive Sleep Apnea in Individuals with Treatment-Resistant Depression. Sleep and Breathing, 2013, 17, (3) 80. Holshausen K, Harvey PD, Elvevag B, Foltz PW, Bowie CR*. Semantic coherence predicts formal thought disorder and adaptive behavior in older inpatients with schizophrenia. Cortex, In Press. *Corresponding author 81. Iftene F, Bowie CR, Milev R, Hawken E, Talikowska-Szymczak E, Potopsingh D, Hanna S, Mulroy J, Groll D, Millson R. Identification of primary polydipsia in a severe and persistent mental illness outpatient population: A prospective observational study. Psychiatry Research, 2013, 210, (1) 82. Lepage M, Bodnar M, Bowie CR. Neurocognition in relation to clinical and functional outcome in schizophrenia. Canadian Journal of Psychiatry, 2014, 59, Harvey PD & Bowie CR. Improving cognition in schizophrenia. Minerva Psichiatrica, In Press. 84. Bowie CR, Grossman M, Gupta M, Oyewumi LK, Harvey PD. Cognitive remediation in schizophrenia: efficacy and effectiveness in patients with early versus long-term course of illness. Early Intervention in Psychiatry, 2014, 8, (5) 85. Holshausen K, Bowie CR*, Mausbach BT, Patterson TL, Harvey PD. Neurocognition, functional capacity, and functional outcomes: The cost of inexperience. Schizophrenia Research, 2014, 152, *Corresponding Author (2) 86. Porter RJ, Bowie CR, Jordan J, Malhi G. Cognitive remediation as a treatment for major depression a rationale, review of evidence, and recommendations for future research. Australia and New Zealand Journal of Psychiatry, 2013, 47, Ho J, Moore R, Cardenas V, Bowie CR, Patterson TL, Mausbach, BT. Direct and mediated effects of cognitive function with multidimensional outcome measures in schizophrenia: the role of functional capacity. Journal of Clinical and Experimental Neuropsychology, 2013, 35(8) Depp CA, Strassnig M, Mausbach BT, Bowie CR, Wolyniec P, Thornquist MH, Luke JR, McGrath JA, Pulver AE, Patterson TL, Harvey PD. Association of obesity and treated hypertension and diabetes with cognitive ability in bipolar disorder and schizophrenia. Bipolar Disorders, In Press.

14 CR Bowie, p Chengappa KNR, Bowie CR, Schlicht PJ, Fleet D, Brar JS, Jindal R. Randomized placebocontrolled adjunctive study of an extract of Withania somnifera for cognitive dysfunction in bipolar disorder. J Clin Psychiatry, 2013, 74: Best MW, Gupta M, Bowie CR*, Harvey PD. A longitudinal examination of the moderating effects of symptoms on the relationship between functional competence and real world functional performance in schizophrenia. Schizophrenia Research: Cognition, In Press. *Corresponding Author 91. Reichenberg, A, Feo, C, Prestia, D, Bowie, CR, Patterson, TL, Harvey, PD. The course and correlates of everyday functioning in schizophrenia. Schizophrenia Research: Cognition, 2014, 1(1) Holshausen, K, Harvey, PD, Elvevåg, B, Foltz, PW, Bowie, CR*. Latent semantic variables are associated with formal thought disorder and adaptive behavior in older inpatients with schizophrenia. Cortex, 2014, 55, (2) 93. Gupta, M, Holshausen, K, Gou L, Bowie, CR*. Measuring negative symptom change in schizophrenia: considering alternatives to self-report. Expert Rev Neurother, 2014, 14(8), Heenan, A, Best, MW, Oullette, SJ, Meiklejohn, E, Troje, NF, Bowie, CR*. Assessing threat responses towards the symptoms and diagnosis of schizophrenia using visual perceptual biases. Schizophrenia Research, In Press. 95. Porter, RJ, Douglas, K, Jordan, J, Bowie, CR, Roiser, J, Malhi, GS. Psychological treatments for cognitive dysfunction in major depressive disorder: current evidence and perspectives. CNS and Neurological Disorders Drug Targets, In Press. 96. Best, MW, Grossman, M, Oyewumi, K, Bowie, CR. An examination of the positive and negative syndrome scale (PANSS) factor structure and longitudinal relationships with functioning in early psychosis. Early Intervention in Psychiatry, In Press. 97. Xavier, S, Best,MW, Schorr, E, Bowie, CR. Neurocognition, functional competence, and selfreported functional impairment in psychometrically defined schizotypy. Cognitive Neuropsychiatry, In Press. EDITED BOOKS 1. Medalia A, Bowie CR. Cognitive Remediation to Improve Functional Outcomes, Oxford University Press, Contract Accepted, Book in Progress BOOK CHAPTERS Supervised students and post-doctoral fellows are italicized 1. Harvey PD & Bowie CR. The clinical neuropsychology of schizophrenia. In M Gelder, J Lopez- Ibor, N Andreasen, & J Geddes (Eds) New Oxford Textbook of Psychiatry, 2 nd ed

15 CR Bowie, p Bowie CR. Delusional Disorder. In I Weiner & E Craighead (Eds) Encyclopedia of Psychology, 4 th ed., Harvey PD & Bowie CR. Schizophrenia spectrum disorders. In G Stricker & TA Widiger (Eds) Handbook of Psychology, Volume 8: Clinical Psychology, 2012 ISBN-10: Bowie CR, Gupta M, Holshausen K. Comparative impairments across schizophrenia and bipolar disorder. In PD Harvey (Ed) Cognitive Impairment in Schizophrenia: Characteristics, Assessment, and Treatment, In Press. 5. Harvey PD, Bowie CR. Cognitive deficits in psychiatric disorders. In Husain M & Schott J (Eds) Cognitive Neurology & Dementia, In Press. REVIEWS OF SCHOLARLY WORK Bowie CR, Reichenberg A, Patterson TL, Heaton RK, Harvey PD. Determinants of Real World Functional Performance in Schizophrenia Subjects: Correlations with Cognition, Functional Capacity, and Symptoms. American Journal of Psychiatry, 2006, 163, Carpenter WT. Targeting schizophrenia research to patient outcomes. American Journal of Psychiatry, 2006, 163, Bowie CR, McGurk SM, Mausbach BT, Patterson TL, Harvey PD. Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real world behavior. American Journal of Psychiatry, 2012, 169, Lehman AF. Making a difference (Editorial). American Journal of Psychiatry, 2012, Continuing Medical Education: American Journal of Psychiatry 3. In Review Podcast, American Journal of Psychiatry 4. Editor s Choice for Article of the Year 2012, American Journal of Psychiatry ORAL PRESENTATIONS (SELECTED) Enhancing Cognition and Function in Older Patients with Serious Mental Illness: A Focus on Cognitive- Behavioural Therapy and Skills Training. Workshop, Center for Addiction and Mental Health, Toronto, ON, 10 Oct Premorbid Adjustment and Current Societal Factors Contribute to the Prediction of Functional Outcome in Schizophrenia. Symposium Session, Society for Research in Psychopathology, Evanston, IL, 19 Sept Cognition in Bipolar Disorder: Profile of Impairment and Strategies for Treatment. Invited Talk, Sunnybrook Hospital, Toronto, ON, 19 August Cognitive Remediation: New Methods for Improving Functioning and Reaching Underserved Populations. Invited Talk, Douglas Institute, Montreal, QC, 26 Jun Rehabilitation of the Patient with Schizophrenia. Invited Talk, Fundacion Cerebro y Mente Conference, Madrid, Spain, 21 Jun Cognitive Remediation Methods to Enhance Functional Outcomes. Invited Plenary Talk, Cognitive Remediation in Psychiatry Conference, New York, 6 Jun 2014.

16 CR Bowie, p. 16 Early Intervention Programs should not Discourage Struggle and Failure: They are Developmentally Typical and Critical Experiences. Invited Talk, Queen s University Department of Psychiatry Research Day, Kingston, ON, 30 May The Experience of Psychosis across Mental Disorders. Invited Talk, Educational Workshop Presented by the Centre for Abuse and Trauma Therapy, Kingston, ON, 23 May Functional Capacity Measures. Invited Talk, The International Society for CNS Clinical Trials and Methodology, 20 March Selecting Patients for Cognitive Treatment Trials. Invited Talk, The International Society for CNS Clinical Trials and Methodology, 20 March Raising the Bar Moving Beyond Symptom Reduction and Targeting Everyday Functioning as the Barometer for Treatment Success in Mental Disorders. Invited Talk, Healthy Minds Canada, Kingston ON, Sept Neurocognitive Enhancement for Treatment-Resistant Depression: Efficacy, Effectiveness, and the Role of Internet-Based Homework. Invited Talk, Cognitive Remediation in Psychiatry Conference, June Cognitive Remediation for Treatment Resistant Depression. Invited Talk, Psychiatry Research Day, Queen s University, Kingston, ON, June Cognitive Remediation in Schizophrenia: Maximizing Efficacy and Promoting Effectiveness. Invited Talk, Centre for Addiction and Mental Health, Toronto, April, Incorporating Cognitive-Behavioural Techniques into Cognitive Remediation Therapy. Workshop Presented at Cognitive Remediation in Psychiatry. New York, June 10, Self-reported Quality of Life and Clinician-Reported Functioning in Schizophrenia: Interrelationships and Sensitivity to Neurocognitive Change. The International Congress on Schizophrenia Research. Symposium Presentation. Colorado Springs, April 6, Cognition in Schizophrenia and Bipolar Disorder as a Function of Psychosis Status. Cognition Satellite Conference of the International Congress on Schizophrenia Research. Oral Session. Colorado Springs, April 1, Cognitive Remediation in Schizophrenia: Challenges in Generalizing Neurocognitive Enhancement to Everyday Behavior Change. Winter Conference on Brain Research. Symposium Session. January 24, Neurocognitive Enhancement in Schizophrenia: Generalization to Real World Disability Reduction? Invited Speaker. Cognitive Remediation in Psychiatry. Invited Speaker. June, Prediction and Treatment of Real World Functional Impairments in Schizophrenia. International Conference on Handicap Psychique [MENTAL DISABILITY], Real-World Functioning et Retablissement [RECOVERY], Ecole Normale Supérieure, Paris. Invited Speaker. May, 2010.

17 CR Bowie, p. 17 Functional Disability as a Treatment Target in Psychotic Disorders. Zucker Hillside Hospital, April, Grand Rounds. Assessing and Predicting Social versus Adaptive Impairments in Schizophrenia. Zucker Hillside Hospital. April Research Symposium. Direct and Indirect Predictors of Real World Outcomes in Bipolar Disorder and Schizophrenia. Society for Research in Psychopathology. Symposium. September, Assessment of Disability in Asian Clinical Trials. National Clinical Drug Evaluation Unit. Panel Discussion, May, Preparing for the Academic Job Market. Society for Research in Psychopathology. Panel Discussion. September, Correlates of Lifetime Work Outcomes in Schizophrenia. Society for Research in Psychopathology. Paper Session. September, Cognition and Functional Outcomes in Schizophrenia. University of Medicine and Dentistry of New Jersey. Grand Rounds, November, Direct and mediated effects of cognition on functional outcomes in schizophrenia. Society for Research in Psychopathology. Symposium. September, What are the functional implications of neuropsychological normality in schizophrenia? Society for Biological Psychiatry. Paper Session. May, Predicting real world outcomes from discrete functional and cognitive abilities. International Congress on Schizophrenia Research. Paper Session. April, Cognitive and functional deficits in schizophrenia. Woodhull Hospital, Brooklyn, NY. Grand Rounds. September, Sadder but wiser in schizophrenia. Society for Research in Psychopathology. Paper Session. September, Determinants of functional disability in schizophrenia. Hudson Valley Veteran s Hospital. Grand Rounds, April, Are negative symptoms and cognitive impairment separable treatment targets in schizophrenia? National Clinical Drug Evaluation Unit, Invited Symposium. ONGOING RESEARCH SUPPORT 1. Healthy Minds Canada/Sun Life Financial/Pfizer Canada Research Grant 05/01/14-05/01/16 Action-Based Cognitive Remediation to Improve Vocational Outcomes in Depression

18 CR Bowie, p. 18 This study examines the effects of a novel cognitive remediation treatment that combines simulated work situations with cognitive activation and strategy development. Role: Principal Investigator Total Direct Costs: 98,400 CAD 2. Brain Canada, Famille Chagnon: Interventions for Prevention of 05/01/14-05/01/19 Alzheimer Disease and Related Disorders: Multi-Investigator Research Initiative. Prevention of Alzheimer s Dementia in high risk population: A randomized controlled trial of a combination of cognitive training and brain stimulation This study pairs the cognitive training I have developed with Transcranial Direct Current Stimulation in an older sample at risk for dementia. Role: Co-Investigator; Lead Investigator, Cognitive Remediation and Neuropsychological Assessment (PIs: Tarek Rajji & Benoit Mulsant) Total Direct Costs: 9,996,087CAD 3. Brain and Behavior Foundation, NARSAD Independent Investigator Award 09/01/13-09/01/15 Remote Cognitive Remediation for Schizophrenia This study is examining the efficacy of delivering cognitive remediation to people with schizophrenia in their homes. Role: Principal Investigator Total Direct Costs: 100,000 USD 4. Canadian Institutes of Health Research: Operating Grant 05/01/14-05/01/19 A Randomized Controlled Trial on Group CBT for Social Anxiety in People with a First Episode of Psychosis This study examines a group based treatment on social anxiety and uses my cognitive remediation treatment as a comparison group. Role: Co-Investigator (PI: Martin LePage) Total Direct Costs: 753,875 CAD 5. Ontario Ministry of Research and Innovation 03/02/11 03/02/16 Early Researcher Award Role: Principal Investigator This award helps to cover graduate student stipend and conference travel costs. Total Direct Costs: 150,000 CAD 6. First Episode Psychosis Program, Hotel Dieu Hospital 04/01/10 Annual Renewal Contract Role: Principal Investigator Total Direct Costs per year: 42,000 CAD 7. Canadian Foundation for Innovation 04/01/ / Infrastructure Operating Fund Role: Principal Investigator Total Direct Costs: 22,350 CAD COMPLETED RESEARCH SUPPORT

19 CR Bowie, p NARSAD Young Investigator s Award 7/1/03-6/30/06 Changes in Cognitive Functioning after Pharmacological Treatment in Adolescents At-Risk for Schizophrenia The major goal of this study was to examine changes in neurocognition in adolescents considered prodromal for schizophrenia after they were treated with antipsychotic or antidepressant medications. Role: Principal Investigator Total Direct Costs: 60,000 USD 2. NIMH R44 MH /01/06-05/31/08 Computerized Antipsychotic Evaluation System This was a subcontract to collect normative data for a computerized cognitive battery designed to be used to track cognitive change following antipsychotic medication administration. Role: Local Principal Investigator Total Direct Costs: 17,380 USD 3. NIMH MH /01/07-05/31/12 Silvio Conte Neuroscience Center: White Matter Abnormalities in Schizophrenia This is a Conte Neuroscience Center grant that supports research on clinical characteristics and postmortem neuropathology of schizophrenia. Role: Co-Investigator, Director of Clinical Assessment Total Direct Costs: 7,560,505 USD 4. NIMH MH /01/03-03/31/09 Course of Functional Deficits in Elderly Schizophrenics This is a study of the course of functional deficits in older community dwelling patients with schizophrenia. Older patients are followed with performance-based measures of functional skills and cognitive assessments. Role: Co-Investigator Total Direct Costs: 1,125,000 USD 5. United States Department of Defense GW /01/07-06/30/2011 A randomized, double-blind, placebo-controlled crossover trial of mifepristone in gulf war veterans with chronic multisymptom illness. Changes in cognitive, behavioral, and medical symptoms were examined with the use of a glucocorticoid receptor antagonist in gulf war veterans with chronic multisymptom illness. Role: Co-Investigator Total Direct Costs: 680,000 USD 6. NARSAD 07/01/07-06/30/10 Specificity and Generalizability of Cognitive Remediation and Functional Skills Acquisition Training in Schizophrenia The goal of this project was to assess whether improvement from two behavioral treatments are restricted to the domain they target or generalize to other areas of functioning, as well as to determine whether they are more effective when used sequentially. Role: Principal Investigator Total Direct Costs: 60,000 USD 7. NIMH MH 05/01/07-04/30/13

20 CR Bowie, p. 20 Chronic Psychiatric Disorders: Linking Genes to Functional Outcomes The goal of this study was to identify associations among candidate genes in bipolar disorder and schizophrenia with impairments in functional capacity and functional outcomes. Role: Local Principal Investigator Total Direct Costs: 128,650 USD 8. Queen s University 07/01/08 Research Initiation Grant The purpose of this internal grant is to fund pilot studies that examine cognitive deficits in chronic mental illness. Role: Principal Investigator Total Direct Costs: 67,000 CAD 9. Canadian Foundation for Innovation 12/01/08 Leaders Opportunity Fund Role: Principal Investigator Total Direct Costs: 74,500 CAD 10. Ontario Ministry of Research and Innovation 05/05/09 Leader s Opportunity Fund Role: Principal Investigator Total Direct Costs: 74,500 CAD